Crossmark Global Holdings’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Sell
12,517
-170
-1% -$6.64K 0.01% 775
2026
Q1
$449K Hold
12,687
0.01% 866
2025
Q4
$355K Buy
12,687
+1,797
+17% +$53.8K 0.01% 961
2025
Q3
$327K Buy
10,890
+50
+0.5% +$1.41K ﹤0.01% 1064
2025
Q2
$310K Sell
10,840
-173
-2% -$5.15K 0.01% 1081
2025
Q1
$364K Buy
11,013
+194
+2% +$6.33K 0.01% 1001
2024
Q4
$311K Sell
10,819
-67
-0.6% -$1.93K 0.01% 1030
2024
Q3
$304K Buy
10,886
+28
+0.3% +$747 0.01% 1064
2024
Q2
$262K Sell
10,858
-73
-0.7% -$1.79K 0.01% 1120
2024
Q1
$296K Buy
10,931
+543
+5% +$15.4K 0.01% 1098
2023
Q4
$288K Buy
+10,388
New +$270K 0.01% 1081
2018
Q4
Sell
-5,175
Closed -$220K 1393
2018
Q3
$220K Buy
+5,175
New +$225K 0.01% 1497
2018
Q2
Sell
-5,325
Closed -$309K 1588
2018
Q1
$309K Sell
5,325
-2,005
-27% -$117K 0.01% 1248
2017
Q4
$401K Buy
7,330
+555
+8% +$28.3K 0.01% 1160
2017
Q3
$344K Buy
+6,775
New +$362K 0.01% 1218
2016
Q3
$344K Buy
+6,775
New +$322K 0.01% 1218

Other funds holding ALKS

Crossmark Global Holdings's ALKS Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Alkermes (ALKS) stake by 1.3% in Q2 2026, selling an estimated $6.64K and leaving 12,517 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #775.

Crossmark Global Holdings first reported a position in ALKS in Q3 2016 and has held it in 16 quarters since. 37 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Crossmark Global Holdings held 12,517 shares of Alkermes worth $656K as of Q2 2026.
  • Crossmark Global Holdings sold 170 Alkermes shares in Q2 2026, an estimated $6.64K.
  • Alkermes made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #775 holding.
  • Crossmark Global Holdings first reported a position in Alkermes in Q3 2016 and has held it in 16 quarters since.
  • 37 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.